Health insurers warned that a move by the Trump administration on Saturday to temporarily suspend a program that was set to pay out $10.4 billion to insurers for covering high-risk individuals last year could drive up premium costs and create marketplace uncertainty.
The Trump administration on Saturday halted billions of dollars in payments to health insurers under the Obamacare healthcare law, saying that a recent federal court ruling prevents the money from being disbursed.
Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer's drug showed positive results for patients who received the highest dose.
(Reuters Health) - The knowledge that getting a flu shot can help prevent flu from spreading in the community may help convince more people to get vaccinated, a U.S. study suggests.
(Reuters Health) - People who can see wind turbines from their homes may be more annoyed by these machines and more likely to report quality of life issues than individuals who live further away from wind turbines, an industry-supported study suggests.
(Reuters Health) - Children whose mothers stick to healthy lifestyle practices are less likely to be obese than children of less healthy moms, researchers report.
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.
A number of high blood pressure and heart drugs containing an ingredient made in China are being recalled across Europe after an impurity that may cause cancer was found in them, officials said on Thursday.
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.
A U.S. private citizen who visited China has reported symptoms like those of U.S. diplomats afflicted with a mysterious illness in Havana and Guangzhou, a U.S. State Department official said on Thursday.
Scientists have created hybrid embros from the sperm of near-extinct northern white rhinoceroses in the laboratory, hoping they can ultimately help save the species. Scarlett Cvitanovich reports.
You might like...
Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.
